# A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

> **NCT00160433** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 131 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00160433
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2008-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160433, "A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00160433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*